Wilke, Michael H. http://orcid.org/0000-0002-0294-1897
Preisendörfer, Birgit
Seiffert, Anna
Kleppisch, Maria
Schweizer, Caroline
Rauchensteiner, Stephan
Funding for this research was provided by:
Pfizer Pharmaceuticals
MSH Medical School Hamburg - University of Applied Sciences and Medical University
Article History
Received: 5 February 2022
Accepted: 27 April 2022
First Online: 31 May 2022
Declarations
:
: MW is Professor for Hospital Management at Medical School Hamburg (MSH) as well as shareholder and managing director of inspiring-health GmbH which received a research grant from Pfizer Pharma GmbH to conduct the study presented. He is also shareholder of Pfizer Inc. He received honoraria for lectures and research grants unrelated to this research from Orion Pharma, Shionogi, Abbott, Accelerate, and bioMérieux. BP is senior consultant at inspiring-health GmbH. AS is senior researcher at GFL, which received honoraria for providing the data from DADB. MK, CS, and SR are employees of Pfizer Pharma GmbH which funded this research.
: An approval of an ethics committee was not necessary. This study was performed with retrospective, anonymized patient data from large databases.